Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.
Press releases published on August 19, 2025
Global Central Lab Services Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 19, 2025
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global Central Lab Services Market, valued at US$5.64 billion in 2024, stood at US$5.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a …
Global Negative Pressure Wound Therapy Market to Surpass USD 3.84 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 19, 2025
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global negative pressure wound therapy market, valued at US$2.59 billion in 2024, stood at US$2.76 billion in 2025 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2030, …
Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
GlobeNewswire
·
August 19, 2025
Pemvidutide is the only drug currently granted Fast Track Designation in AUD RECLAIM, a Phase 2 trial of pemvidutide in AUD, is currently enrolling GAITHERSBURG, Md., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage …
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
GlobeNewswire
·
August 19, 2025
WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today …
Orezone Intercepts Further High-Grade Mineralization Below Life of Mine Pits Including 1.59 g/t Gold Over 48.00m and 1.09 g/t Gold Over 45.00m
GlobeNewswire
·
August 19, 2025
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE | ASX: ORE | OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to provide additional drill results from its ongoing multi-year exploration campaign at its …
Xtract One Announces Upcoming Investor Events
GlobeNewswire
·
August 19, 2025
TORONTO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced that the Company will participate in the following three events during September and October, 2025: …
Angitia Biopharmaceuticals to Present Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
GlobeNewswire
·
August 19, 2025
- Angitia abstracts selected for two oral presentations and three posters - Angitia collaborator also selected for poster presentation WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology …
Mercury Signs New Hardware Production Agreement with AV to Support U.S. Space Force’s SCAR Program
GlobeNewswire
·
August 19, 2025
ANDOVER, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing to the edge, today announced a new production agreement with AeroVironment, Inc. (“AV”) ( …
Atana Welcomes Jeff Carr as President
GlobeNewswire
·
August 19, 2025
BELLEVUE, Wash., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Atana, the behavior-based learning and development software company that helps improve workforce employee engagement, productivity, and retention, today announced that industry expert, Jeff Carr, has been …
BioXcel Therapeutics Announces Database Lock in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
GlobeNewswire
·
August 19, 2025
Data from more than 2,600 agitation episodes collected Topline data readout is on track for August NEW HAVEN, Conn., Aug. 19, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …
Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science
GlobeNewswire
·
August 19, 2025
First-in-human, Phase I, randomized, placebo-controlled study, successfully demonstrated safety and tolerability of potravitug in healthy volunteers The Company recently announced the results from its Phase II placebo-controlled clinical trial of …
Firecrawl Announces $14.5 Million in Series A Funding to Put Web Data on Tap for AI Agents
GlobeNewswire
·
August 19, 2025
Round led by Nexus Venture Partners with participation from Y Combinator, Shopify’s CEO Tobias Lütke and existing and new angel investors Firecrawl is the fastest-growing commercial open-source scraping tool, radically transforming web data into AI-powered …
Castellum, Inc. and Tradewinds Networks, Inc. Announce Execution of Reseller Agreement
GlobeNewswire
·
August 19, 2025
VIENNA, Va., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) (the “Company” and “Castellum”) and Tradewinds Networks, Inc. (“TNI”) are pleased to jointly announce that the Company’s newly formed product subsidiary, Castellum Advanced …
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
GlobeNewswire
·
August 19, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics today announced the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent No. US-2022/0133806 A1, covering the company's …
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
GlobeNewswire
·
August 19, 2025
STAFFORD, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
August 19, 2025
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Trident Mengumumkan Pelaburan Strategik dalam Syarikat E-Dagang Web 3.0, Tongxin Innovation Limited
GlobeNewswire
·
August 19, 2025
SINGAPURA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” atau “Syarikat,” NASDAQ: TDTH), sebuah syarikat berpangkalan di Singapura yang menjadi pemangkin transformasi digital dan pengaktifan Web 3.0, hari ini mengumumkan …
Trident ประกาศการลงทุนเชิงกลยุทธ์ใน Tongxin Innovation Limited ซึ่งเป็นบริษัทอีคอมเมิร์ซ Web 3.0
GlobeNewswire
·
August 19, 2025
สิงคโปร์, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd ("Trident" หรือ "บริษัท" NASDAQ: TDTH) บริษัทผู้นำการผลักดันการเปลี่ยนแปลงดิจิทัลและการเปิดใช้งาน Web 3.0 ที่ตั้งอยู่ในสิงคโปร์ ประกาศวันนี้ว่า บริษัทได้ลงนามในข้อตกลงซื้อขาย (" …
Trident công bố khoản đầu tư chiến lược vào hãng thương mại điện tử Web 3.0, Tongxin Innovation Limited
GlobeNewswire
·
August 19, 2025
SINGAPORE, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” hoặc “Công ty”, NASDAQ: TDTH), một công ty có trụ sở tại Singapore với năng lực thúc đẩy hoạt động chuyển đổi số và áp dụng công nghệ Web 3.0, hôm nay đã thông báo về …
Trident Mengumumkan Investasi Strategis pada E-Commerce Web 3.0 Milik Perusahaan Tongxin Innovation Limited
GlobeNewswire
·
August 19, 2025
SINGAPURA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” atau “Perusahaan,” NASDAQ: TDTH), katalis berbasis Singapura untuk transformasi digital dan aktivasi Web 3.0 hari ini mengumumkan pihaknya telah mengadakan perjanjian …